Abstract
Features| March 2021 Deskilling of Anesthetic Drugs Peiman Lahsaei, MD; Peiman Lahsaei, MD Search for other works by this author on: This Site PubMed Google Scholar Christopher Choi, MD; Christopher Choi, MD Search for other works by this author on: This Site PubMed Google Scholar Girish P. Joshi, MBBS, MD, FFARCSI Girish P. Joshi, MBBS, MD, FFARCSI Search for other works by this author on: This Site PubMed Google Scholar ASA Monitor March 2021, Vol. 85, 24–25. https://doi.org/10.1097/01.ASM.0000737076.46363.0c Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Share Icon Share Facebook Twitter LinkedIn Email Cite Icon Cite Get Permissions Search Site Citation Peiman Lahsaei, Christopher Choi, Girish P. Joshi; Deskilling of Anesthetic Drugs. ASA Monitor 2021; 85:24–25 doi: https://doi.org/10.1097/01.ASM.0000737076.46363.0c Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search nav search search input Search input auto suggest search filter All ContentAll PublicationsASA Monitor Search Advanced Search Topics: anesthesia, total intravenous, medication shortages, pain management, professors, methohexital, barbiturates, pain, propofol, care of intensive care unit patient, electroconvulsive therapy Critical drug shortages have been widespread during the SARS-CoV-2 pandemic, especially regarding intravenous sedatives for patients on mechanical ventilation (Mayo Clin Proc 2020;95:1112-5). Unfortunately, drug shortages are not a new phenomenon and have been increasing in number, while disproportionately affecting anesthesia medications, antibiotics, pain medications, nutrition and electrolyte products, and chemotherapy agents (Mayo Clin Proc 2014;89:361-73). There is no one-stop solution since no regulatory agency can require manufacturers to produce a specific product. Increased global demand, consolidation of production, and changes in regulatory standards all play a causative role (Bull World Health Organ 2012;90:158-158A). Economics is the elephant in the room: there is a lack of incentive for manufacturers to produce less profitable drugs. As anesthesiologists, we must be flexible and adapt to this shifting landscape. The American Medical Association recently defined deskilling... © 2021 American Society of Anesthesiologists (ASA), All Rights Reserved.2021 You do not currently have access to this content.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
